Health Care: Drugs

Clovis Oncology Inc (CLVS: NASDAQ)

$61.19 -1.8 | -2.86%
02/22/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 62.99
52 Week High 67.16
52 Week Low 11.57
Avg. Daily Vol. (Mil) 2.38
Beta (3 year) 2.19
Share Related Items
Mkt Cap (Mil) 2,792.70
Shares Out (Mil) 44.34
Float (Mil) 33.11
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.40
Current Ratio 5.60
LT Debt/ Equity 4.92
Total Debt / Equity 4.92
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 48.96
Price/Cash Flow -7.10
Per Share Data
Earnings -10.41
Sales 0.00
Book Value 1.29
Cash Flow -8.92
Business Summary
Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets.
General Information
5500 Flatiron Parkway
Suite 100
Boulder, CO 80301
Industry : Drugs
Sector: Health Care
Employees: 309
CEO: Patrick J. Mahaffy
Short Interest
Current Month (Mil) 7.27
Previous Month (Mil) 7.44
Short Interest Ratio (Days) 2.40
Management Effectiveness
Return on Equity n.a.
Return on Assets -99.80
Return on Investments -117.80
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with CLVS

Latest CLVS Headlines from TheStreet

More Financial News for CLVS

Press Releases for CLVS

See All Press Releases

Partner Headlines for CLVS

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter